CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 113 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,141,003 | -22.7% | 87,782 | 0.0% | 0.02% | -34.5% |
| Q4 2022 | $2,768,644 | +11.6% | 87,782 | 0.0% | 0.03% | 0.0% |
| Q3 2022 | $2,481,000 | -32.5% | 87,782 | -16.4% | 0.03% | -29.3% |
| Q1 2022 | $3,676,000 | -70.7% | 105,000 | -75.3% | 0.04% | -73.5% |
| Q3 2021 | $12,531,000 | -40.7% | 424,767 | -48.5% | 0.16% | -36.5% |
| Q2 2021 | $21,121,000 | +51.9% | 824,389 | -18.6% | 0.24% | +36.3% |
| Q1 2021 | $13,901,000 | -37.5% | 1,012,480 | -24.5% | 0.18% | -43.0% |
| Q4 2020 | $22,242,000 | – | 1,341,485 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,005,284,000 | 38.09% |
| Ally Bridge Group (NY) LLC | 1,767,440 | $29,304,000 | 5.02% |
| Affinity Asset Advisors, LLC | 270,000 | $4,477,000 | 2.37% |
| SPHERA FUNDS MANAGEMENT LTD. | 811,665 | $13,457,000 | 1.19% |
| Artal Group S.A. | 2,282,100 | $37,837,000 | 0.81% |
| Perceptive Advisors | 4,544,062 | $75,340,000 | 0.81% |
| RA Capital Management | 2,200,000 | $36,476,000 | 0.51% |
| Monashee Investment Management LLC | 200,000 | $3,316,000 | 0.44% |
| Boxer Capital, LLC | 714,500 | $11,846,000 | 0.38% |
| EcoR1 Capital, LLC | 400,000 | $6,632,000 | 0.36% |